Givaudan | GIVN - Current Liabilities



Givaudan reported CHF2.97B in Current Liabilities for its fiscal semester ending in June of 2024.


Current Liabilities Change Date
Air Liquide EUR 9.54B 51.7M Jun/2025
Akzo Nobel EUR 5.16B 371M Jun/2025
Anheuser-Busch USD 33.01B 57M Jun/2025
Arkema EUR 1.62B 201M Jun/2025
Associated British Foods GBP 3.71B 46M Mar/2025
BASF EUR 18.18B 74M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Beiersdorf EUR 3.77B 6.12B Jun/2025
British American Tobacco GBP 18.04B 2.37B Jun/2024
Covestro EUR 4.04B 719M Jun/2025
Croda International GBP 547.7M 209.7M Dec/2024
Danone EUR 13.62B 116M Jun/2025
Diageo GBP 10.71B 241M Jun/2025
Fresenius EUR 8.3B 33M Jun/2025
Fresenius Medical Care EUR 5.66B 213.7M Jun/2025
Givaudan CHF 2.97B 911M Jun/2024
Glanbia USD 1.05B 149.1M Jan/2025
Heineken EUR 14.86B 626M Jun/2025
Henkel EUR 8.54B 549M Jun/2025
International Flavors Fragrances USD 3.18B 1.42B Jun/2025
Johnson Matthey GBP 2.48B 36M Mar/2025
Kerry EUR 2.91B 815.6M Dec/2024
Lonza CHF 3.58B 970M Dec/2024
L'Oréal EUR 15.4B 764.3M Jun/2025
Merck EUR 9.86B 357M Jun/2025
Nestle CHF 46.82B 3.96B Jun/2025
Pernod Ricard EUR 6.44B 183M Jun/2025
Reckitt Benckiser GBP 7.94B 901M Dec/2024
SGS CHF 2.53B 53M Dec/2024
Sika AG CHF 2.59B 750.7M Dec/2024
Solvay EUR 1.61B 105M Jun/2025
Tate & Lyle GBP 609M 255M Mar/2025
Umicore EUR 3.53B 819.1M Jun/2025
Victrex 51.3M 5.4M Mar/2025